Why is Emmessar Biotech falling/rising?

As of 21-Aug, Emmessar Biotech & Nutrition Ltd's stock price is currently at 28.67, reflecting an increase of 0.87 or 3.13%. The stock has shown a positive performance today, outperforming its sector by 3.11%, and has been on a consecutive gain for the last two days, accumulating a total return of 6.15% during this period. While the stock has been underperforming over the longer term, with a year-to-date decline of 38.08%, it has recently seen a rise in investor participation, with delivery volume increasing by 154.63% against the five-day average. However, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
Broader Market Context: In comparison to the benchmark, the stock has outperformed the Sensex in the short term, with a one-week return of 2.98% versus the Sensex's 1.74%. Despite this recent uptick, the stock's longer-term performance remains concerning, as it has declined significantly over the past month and year, while the Sensex has shown modest gains. This context suggests that while the stock is experiencing a short-term rebound, its overall performance relative to the market remains weak.